A randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy (GDH) program (Nerva) to an active control found that GDH significantly improved IBS symptoms and quality of life. Among 240 participants, 81% of those using the GDH program experienced a ≥50-point decrease in IBS symptom severity compared to 63% in the control group (P = 0.002). GDH also led to a greater reduction in pain (71% vs. 35%, P < 0.001) and quality-of-life improvements (P < 0.001). These findings support digital GDH as an effective and accessible alternative to in-person behavioral interventions for IBS management.
Trending
- ‘Tremendous implications’: Hospital affiliation linked to higher-cost care (Healio)
- Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients (HIT Consultant)
- 10 Must-Read Posts in GI Oncology This Week (OncoDaily)
- SCA Health expands GI footprint, physician network in 2025 (Becker’s GI & Endoscopy)
- 7 key numbers on the state of GI in 2025 (Becker’s GI & Endoscopy)
- White House Unveils ‘TrumpRx’ Drug-Buying Site and a Pfizer Pricing Deal (The Wall Street Journal)
- CADe for Colonoscopy: Positive and Negative Takeaways From Largest Real-World Study (GI & Endoscopy News)
- FDA OKs Tremfya for Ulcerative Colitis (GI & Hepatology News)